SCHEMBL8097069

SCHEMBL8097069

CCC(c1ccccc1)C(F)F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HKDC1 Q2TB90 1/20 0.52
LMNA P02545 3/20 0.48
TAAR1 Q96RJ0 4/20 0.45
SLC6A2 P23975 4/20 0.43
SLC6A3 Q01959 4/20 0.43
HSD17B10 Q99714 1/20 0.43
ESR1 P03372 1/20 0.43
CYP1A2 P05177 1/20 0.43
PGR P06401 1/20 0.43
CHRM2 P08172 1/20 0.43
CYP3A4 P08684 1/20 0.43
ADORA3 P0DMS8 1/20 0.43
AR P10275 1/20 0.43
CYP2D6 P10635 1/20 0.43
MAPT P10636 1/20 0.43
CHRM1 P11229 1/20 0.43
CYP2C9 P11712 1/20 0.43
ALOX15 P16050 1/20 0.43
DRD1 P21728 1/20 0.43
TBXA2R P21731 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4071581 0.85 HKDC1 (0.65) HKDC1LMNATAAR1SLC6A2SLC6A3
SCHEMBL8089685 0.82 AOC3 (0.43) HKDC1LMNATAAR1SLC6A2SLC6A3
SCHEMBL3861713 0.80 HKDC1 (0.55) HKDC1LMNATAAR1SLC6A2SLC6A3
Ammonia Solution, Strong SCHEMBL18191766 0.78 HKDC1 (0.53) HKDC1LMNATAAR1SLC6A2SLC6A3
SCHEMBL12821932 0.78 TAAR1 (0.41) HKDC1TAAR1SLC6A2SLC6A3CYP1A2
SCHEMBL11206738 0.78 HKDC1 (0.53) HKDC1LMNATAAR1SLC6A2SLC6A3
SCHEMBL598978 0.78 TAAR1 (0.64) HKDC1LMNATAAR1SLC6A2SLC6A3
SCHEMBL14945067 0.76 TAAR1 (0.61) TAAR1SLC6A2SLC6A3CYP1A2CYP3A4
SCHEMBL21558017 0.76 SLC6A2 (0.42) HKDC1LMNATAAR1SLC6A2SLC6A3
SCHEMBL22009966 0.76 HKDC1 (0.52) HKDC1LMNATAAR1SLC6A2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100266714-A1 P2X3 RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN MERCK SHARP & DOHME LLC 2010-10-21 US disclosed
EP-1053990-A2 A method of producing an aromatic ketone and an aromatic ketone composition containing it TORAY INDUSTRIES, INC. (JP) 2000-11-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100266714-A1 P2X3 RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN P2RX3, P2RX1, P2RX2 HKDC1 4384/4885LMNA 4068/4885TAAR1 343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.